We reported on a new joint venture between Nuritas and Stonehaven Incubate that will see Artificial Intelligence (AI) being applied to bioactive peptides to conceive new feed ingredients for animal health. It came in at number 8 in our Top 10 most read stories in August.
Irish biotech company, Nuritas, has a proprietary discovery platform that uses genomics and AI to identify bioactive peptides with health benefits. The software has already been proven in a human health context – it was used to select the plant-based peptides that form the basis of BASF’s PeptAIde inflammation regulating sports nutrition ingredient – and now, Stonehaven Incubate is planning to use the technology to bring to market new animal health ingredients.
Emmet Browne, CEO of Nuritas, told FeedNavigator that two example areas of animal health the partnership could explore are rheumatology and antibiotic alternatives, amongst several others.
“Our focus is on identifying innovative ingredients, extracting them from nature and unlocking their healthcare potential. Stonehaven will draw on its knowledge of animal health to maximize ways of harnessing our technology and its innovations."